The ichthyoses form part of a large, clinically and etiologically heterogeneous group of mendelian disorders of cornification (MEDOC) and typically involve all or most of the integument. [1] [2] [3] During the past few years, much progress has been made in defining the molecular basis of these disorders, and in establishing genotype-phenotype correlations. [4] [5] [6] [7] [8] [9] [10] [11] However, there is no universally accepted terminology and classification of the diseases considered under the umbrella term ''ichthyosis.'' Classification schemes and terminology continue to vary greatly among European, North American, and Asian countries. For example, the same entity may be referred to as epidermolytic hyperkeratosis, bullous congenital ichthyosiform erythroderma (CIE), or bullous ichthyosis, depending on where it is diagnosed. 9 Therefore, a new consensus project was initiated at the First World Conference on Ichthyosis 2007 in Münster, Germany (http://www.netzwerk-ichthyose. de/fileadmin/nirk/uploads/Program.pdf). The subsequent process of correspondence involved more than 37 dermatologists, skin pathologists, biologists, and geneticists active in the field of ichthyoses. The discussions led to the 2009 Ichthyosis Consensus Conference on the terminology and classification of inherited ichthyoses, held in Sorèze, France (http:// www.netzwerk-ichthyose.de/index.php?id=28&L=1).
Subcommittees were formed to address controversial issues including both terminology and nosology. The consensus achieved is presented in Tables I to  III. Tables IV to XII summarize the clinical and morphologic findings of the inherited ichthyoses. Importantly, the clinical classification developed at the conference is consistent with current understanding of molecular causes and pathophysiology, as summarized in Table XIII , and should be amenable to modification as new information emerges.
AIMS AND LIMITATIONS OF THE CONSENSUS REPORT
The overall goal of the revised classification is to clarify the terminology of this heterogeneous group of inherited skin diseases ( Table I ). The classification scheme and nosology should be easily understandable for all clinicians, biologists, and students. It should guide clinicians toward the correct genotyping of their patients and facilitate communication with investigators. The proposed classification (Tables II  and III ) will need to be modified or expanded as new information accrues. A pathophysiologic classification of the ichthyoses and all MEDOC should be initiated in the future (Table XIII) .
RECOMMENDED REVISION OF THE TERMINOLOGY AND CLASSIFICATION OF INHERITED ICHTHYOSIS
The generic term ''inherited ichthyosis'' refers to diseases that are MEDOC affecting all or most of the integument. The skin changes are clinically characterized by hyperkeratosis, scaling, or both. Despite concern among some participants that the term ''ichthyosis'' 2 is outmoded and sometimes inaccurate, the consensus was to retain it, as it is too firmly entrenched in the literature and minds of clinicians to be abandoned. Inherited ichthyoses are regarded as one disease group within the greater group of MEDOC. For greater clarity, we redefined some important clinical and dermatologic terms that are in common usage (Table I) . Specifically, the revised classification is based on consent to a specific definition of the term ''autosomal recessive congenital ichthyosis'' (ARCI), and a major change to nomenclature of the ichthyoses caused by keratin mutations (see below).
General framework for the revised classification system
At present, molecular diagnosis is not available for all forms of ichthyosis, and access to genetic diagnostics may be impeded by the high cost of analysis. Similarly, ultrastructural techniques are not in common clinical use by pathologists and are not widely available to clinicians. Other laboratory techniques, including light microscopy, narrow the differential diagnoses in some cases (see ''Diagnostic Aspects'' section), but decisions regarding further testing, ie, molecular diagnostics, rest on an initial, rigorous clinical evaluation. Therefore, the result of the consensus discussion process is a clinically based classification, in which the diseases are referenced with the causative gene or genes. Two principal groups are recognized: nonsyndromic forms (Table II) and syndromic forms (Table  III) . This algorithm is in the tradition of previous concepts 3, [12] [13] [14] and based on the following question: Noteworthy, recessive X-linked ichthyosis (RXLI) is regarded as syndromic when accompanied by associated manifestations such as testicular maldescent, and nonsyndromic when ichthyosis occurs as an isolated type 3 without extracutaneous signs. To facilitate the readability and understanding of the long list of autosomal ichthyosis syndromes, subheadings have been introduced that point to the prominent associated signs, eg, hair abnormalities or neurologic signs (Table III) .
Another question distinguishes between congenital ichthyosis and ichthyoses of delayed onset. This criterion is important for common ichthyoses (Table  IV) , namely ichthyosis vulgaris (IV) and RXLI, which often have a delayed onset (Fig 1) . However, early subtle skin changes may be overlooked, eg, RXLI may present with fine superficial scaling shortly after birth, which may fade within weeks and recur as a clear ichthyosis in later life. Therefore, considering the high variability of the initial disease presentation of some ichthyoses, eg, TTD, the age of onset has not been chosen as a major classification criterion.
CAPSULE SUMMARY d
Inherited ichthyoses belong to a large and heterogeneous group of mendelian disorders of cornification and involve the entire integument. A conference of experts was convened to reach a consensus on terminology and classification and to provide an internationally accepted frame of reference.
d
The classification remains clinically based and distinguishes between syndromic and nonsyndromic ichthyosis forms. Bullous ichthyosis/epidermolytic hyperkeratosis is redefined as keratinopathic ichthyosis. Autosomal recessive congenital ichthyosis refers to harlequin ichthyosis, lamellar ichthyosis, and congenital ichthyosiform erythroderma.
Classification of ARCI
The acronym ''ARCI'' has been used as an umbrella term for nonsyndromic disorders, eg, LI and CIE, and for syndromic types of ichthyosis, such as Netherton syndrome (NS). We propose that ''ARCI'' should be used to refer to harlequin ichthyosis (HI) and disorders of the LI/CIE phenotypic spectrum (Table V) exclusively. HI (Fig 2, A) was included, because functional null mutations in the ABCA12 gene cause the disease, 15, 16 whereas missense mutations in the same gene may result in a milder phenotype that shows collodion membrane at birth and develops into LI 17, 18 or CIE, 19, 20 often with palmoplantar keratoderma (PPK). Those infants with HI who survive the perinatal period go on to express a severe and very scaling erythroderma 21 ( Fig 2, B and C ) .
One difficulty of the ARCI classification is the limited genotype-phenotype correlation within the LI/CIE spectrum. Mutations in 6 genes have been described in non-HI ARCI to date, including TGM, the gene encoding transglutaminase (TGase)-1, 22, 23 the genes ABCA12, 17 NIPAL4 (also known as ICHTHYIN ), 24 CYP4F22, 25 and the lipoxygenase genes ALOX12B and ALOXE3.
26 A large cohort of 520 affected families showed a mutation distribution of 32% for TGM1, 16% for NIPAL4, 12% for ALOX12B, 8% for CYP4F22, 5% for ALOXE3, and 5% for ABCA12, 27 which approximately correlated with a recent report of 250 patients. 28 At least 22% of these cases did not exhibit mutations in any of the known ARCI genes, 27 implying that further loci must exist, such as two loci on chromosome 12p11.2-q13. 29, 30 A preliminary clinicogenetic correlation based on the [17] [18] [19] [20] and our discussions at the consensus conference is given in Tables II and III. LI is characterized by coarse and brown/dark scaling (Fig 2, E and F ) . Affected individuals are often born with collodion membrane and pronounced ectropion (Fig 2, D) . CIE is characterized by fine, white scaling with varying degrees of erythema (Fig 2, G and H ) . Individuals with CIE may also be born with collodion membrane (often less severe), and then transit to generalized fine scaling and pronounced erythroderma. 31, 45 The phenotypes can change over time and in response to treatment, eg, LI treated with oral retinoids can evolve into an erythrodermic ichthyosis with a finer scale pattern. 46 In a recent North American study of 104 patients with non-HI ARCI, mutations in TGM1 were significantly associated with collodion membrane, ectropion, platelike scales, and alopecia. Patients who had at least one mutation predicted to truncate TGase-1 were more likely to have severe Clinically other minor ARCI variants/subtypes can be distinguished: bathing suit ichthyosis 47 has been attributed to particular TGM1 mutations that render the enzyme sensitive to ambient temperature (Fig 2, I ) . 32, 42, 43, 48 The self-healing collodion baby representing approximately 10% of all ARCI cases 36, 49 has so far been associated with TGM1 or ALOX12B mutations. 37, 44 The recently described acral selfhealing collodion baby, ie, at birth the collodion membrane is strictly localized to the extremities and then resolves, can also be a result of TGM1 mutations. 41 
Classification of the keratinopathic ichthyoses
The term ''epidermolytic hyperkeratosis'' derives from the characteristic light microscopic observation of intracellular vacuolization, clumping of tonofilaments, and formation of small intraepidermal blisters, as commonly seen in ichthyoses as a result of keratin mutations. Therefore the term ''epidermolytic hyperkeratosis'' is used (by some) as synonymous with bullous ichthyosis, ichthyosis exfoliativa, bullous CIE (of Brocq), or ichthyosis bullosa of Siemens. [50] [51] [52] [53] [54] [55] However, the light microscopic features of the cytoskeletal abnormalities as a result of keratin mutations may not be observed in all instances. [56] [57] [58] [59] To replace the long list of names, which have been used for these ichthyosesethose that are all a result of keratin mutationsewe propose the novel umbrella term and definition ''keratinopathic ichthyosis'' (KPI) ( Table I ). In analogy to the prevalent morphologic key features, we suggest the term ''epidermolytic ichthyosis'' as a novel name for the specific disease spectrum that is accompanied by epidermolytic hyperkeratosis at the ultrastructural level. The term ''epidermolytic hyperkeratosis'' should be used exclusively as an ultrastructural or histopathological descriptor. We propose the novel disease name ''superficial epidermolytic ichthyosis'' for the welldefined entity ichthyosis bullosa Siemens, which in contrast to EI shows a more superficial pattern of epidermolysis and is caused by mutations in keratin 2, rather than in keratins 1 or 10.
Clinically, KPI show a broad spectrum of skin manifestations and severity (Table VI) . Widespread skin blistering is characteristic of neonates with EI (Fig 3, A) , not seen thereafter except for focal blisters. The blistering phenotype present at birth, which is a result of loss of mechanical resilience in the upper epidermis, evolves into a hyperkeratotic one (phenotypic shift) (Fig 3, C ) ; this is suggested to be influenced primarily by abnormal lamellar body (LB) secretion, rather than corneocyte fragility. 60 Superficial EI (Fig 3, D) has a milder phenotype than EI and can be distinguished by the lack of erythroderma and by a characteristic ''moulting'' phenomenon (Fig 3, F ) . Here, light microscopy and ultrastructure reveal cytolysis that correlates with the distinctive expression pattern of keratin 2 FISH, Fluorescent in situ hybridization; IV, ichthyosis vulgaris; KG, keratohyaline granules; RXLI, recessive X-linked ichthyosis; SC, stratum corneum; SG, stratum granulosum; XR, X-linked recessive. *RXLI within context of contiguous gene syndrome (Table III) , eg, in Kallmann syndrome, chondrodysplasia punctata (brachytelephalangic type), or ocular albinism type 1. in the stratum granulosum (SG) or upper stratum spinosum. 61 Different features such as distribution, erythema, or blistering were used for separating patients with EI into 6 clinical groups, with the most distinctive characteristic being involvement of palms and soles (1-3 vs non-palms and soles 1-3). 62 PPK is usually predictive of a KRT1 mutation (Fig 3, E ) . One explanation is that keratin 9, which is expressed in palms and soles, may compensate for a keratin 10 defect, whereas keratin 1 is the only type II keratin expressed in palmoplantar skin. [63] [64] [65] However, PPK may occur with KRT10 mutations as well. 66 Similar to pachyonychia congenita or the epidermolysis bullosa simplex group, the vast majority of the KPI arise from autosomal dominant mutations. The resulting mutant keratin is normally expressed but interferes with the assembly and/or function of keratin intermediate filaments, often leading to keratin intermediate filament aggregation and cytolysis. However, KRT10 nonsense mutations have been observed that do not lead to the usual dominant negative effect and cause an autosomal recessive KPI form. 67 Therefore, autosomal recessive EI is listed as a new separate KPI. For ichthyosis CurthMacklin, [57] [58] [59] 68 which represents a very rare form of KPI and shows a characteristic ultrastructure (Table  VI) , we propose to omit the adjective ''hystrix'' and retain the eponym Curth-Macklin. Hystrix skin changes can be observed in other ichthyoses, eg, KID syndrome (Table XII) , or in particular types of ectodermal dysplasia. 69 The annular EI (Fig 3, E ) , which is a result of KRT1 or KRT10 mutations, 70, 71 is classified as a clinical variant of EI.
Importantly, linear epidermolytic nevi, ie, those epidermal nevi exhibiting the histopathology of epidermolytic hyperkeratosis, may indicate a somatic type 1 mosaicism for mutations in KRT1 or KRT10, which, if also gonadal, can result in generalized EI in the patient's offspring (Fig 3, A and  G) . [72] [73] [74] Because recognition of this risk is important for genetic counseling, epidermolytic nevi have been included (in brackets) in the classification of KPI (Table II) .
Other diseases considered in the classification of inherited ichthyoses
The inclusion of disease entities into this classification of inherited ichthyosis rests on an appropriate clinical disease description and our definition of inherited ichthyosis (Table I) . A detailed overview of the disease onset, initial clinical presentation, disease course, cutaneous and extracutaneous findings, and of the skin ultrastructure is given for each entity: (1) common forms of ichthyosis (Table IV) ; (2) ARCI (Table V) ; (3) KPI and congenital reticular ichthyosiform erythroderma (Table VI) ; (4) other nonsyndromic ichthyosis forms (Table VII) ; (5) Xlinked ichthyosis syndromes (Table VIII) ; and (6) autosomal ichthyosis syndromes with prominent hair abnormalities (Table IX) , prominent neurologic signs (Table X) , fatal disease course (Table XI) , and other associated signs ( Table XII) . Diseases that are classically regarded as ichthyosis in the previously published scientific literature and that will continue to be included are shown in Figs 4 and 5. They include Sjögren-Larsson syndrome 75, 76 ( Fig 5, B) , Refsum syndrome, 77, 78 neutral lipid storage disease with ichthyosis (also referred to as ChanarinDorfman syndrome) (Fig 5, G) , 40, 79, 80 ichthyosis folliculariseatrichiaephotophobia syndrome (Fig 5,  D) , 81, 82 Conradi-Hünermann-Happle syndrome (CDPX2) (Fig 5, F ) , 83, 84 multiple sulfatase deficiency, 85, 86 congenital reticular ichthyosiform erythroderma also referred to as ichthyosis variegata 87 (or ichthyosis en confettis 88 ) (Fig 4, E ) , and ichthyosis prematurity syndrome 89, 90 (Fig 5, E ) . In ichthyosis prematurity syndrome, affected pregnancies exhibit abnormal amniotic fluid both on ultrasound imaging and clinically. 91 It must be distinguished from the selfhealing collodion baby, because in both diseases the skin heals almost completely soon after birth. 89 Many advances in the heterogeneous field of the TTDs (Fig  5, A) have been made. 92, 93 Recent studies on genotype-phenotype correlation distinguish the TTD syndromes associated with ichthyosis of delayed onset or accompanied with collodion membrane from other forms of TTD. 94 Diseases relatively new in the list of ichthyoses are loricrin keratoderma, also referred to as Camisa variant of Vohwinkel keratoderma (Fig 4, C ) , [95] [96] [97] the cerebral dysgenesiseneuropathyeichthyosisePPK syndrome, 98 the arthrogryposiserenal dysfunctionecholestasis syndrome, [99] [100] [101] the mental retardationeenteropathye deafnesseneuropathyeichthyosisekeratodermia syndrome, 102 the ichthyosisehypotrichosisesclerosing cholangitis syndrome (also known as neonatal ichthyosis sclerosing cholangitis syndrome), [103] [104] [105] the ichthyosis hypotrichosis syndrome (Fig 5, I ) 106 and its allelic variant congenital ichthyosisefollicular atrophodermaehypotrichosisehypohidrosis syndrome, 107, 108 and keratosis lineariseichthyosisecongenital sclerosing keratoderma (Fig 4, F ) . 109, 110 Erythrokeratodermia variabilis (EKV), [111] [112] [113] which is characterized by migratory erythematous patches and more fixed, symmetric hyperkeratotic plaques often with palmoplantar involvement (Fig 4,  B) , is genetically heterogeneous and can in 50% to 65% of cases 114 be caused by mutations in GJB3 coding for the gap junction protein connexin 31, 115 or GJB4 coding for connexin 30.3.
116 Whether Acral PSS, Acral peeling skin syndrome; AD, autosomal dominant; AR, autosomal recessive; CE, cornified cell envelope; CIE, congenital ichthyosiform erythroderma; EKV, erythrokeratodermia variabilis; IE, ichthyosiform erythroderma; KG, keratohyaline granules; KLICK, keratosis lineariseichthyosis congenitaekeratoderma; LB, lamellar body; LK, loricrin keratoderma; PPK, palmoplantar keratoderma; PSD, peeling skin disease; SC, stratum corneum; SG, stratum granulosum.
*We propose to classify disorder as nonsyndromic form and therefore modified name ''peeling skin syndrome (PSS)'' into ''peeling skin disease.'' J AM ACAD DERMATOL OCTOBER 2010 progressive symmetric erythrokeratodermia, 111, 112 which has a considerable clinical overlap with EKV, 113 represents a distinct MEDOC form is debated and depends on future genetic data. At present, it is known that progressive symmetric erythrokeratodermia is heterogeneous and patients of two families given the diagnosis of progressive symmetric erythrokeratodermia were found to have the same GJB4 mutation as others with EKV. 114, 117 Previously, erythrokeratodermia was differentiated from the ichthyosis group as it is not generalized in most cases. However, the majority of the participants thought that the inclusion of EKV into this classification is appropriate and useful and in accordance with the inclusion of KID (keratitiseichthyosisedeafness) syndrome 118, 119 (Fig 5, C ) , which is identical to ichthyosis hystrix type Rheydt 120 or hystrixlike ichthyosis deafness syndrome.
3 KID syndrome is caused by heterozygous mutations in GJB2 (connexin 26) 121 and patients with congenital presentation in particular have generalized skin involvement. In some cases, it may overlap with Clouston syndrome, which is caused by mutations in GJB6 (connexin 30). 69, 122 One could argue that NS 123 (Fig 5, H ) should not be classified with the ichthyoses, because it is characterized by premature desquamation and a thinner rather than thicker stratum corneum (SC). However, the clinical features often overlap with the CIE phenotype, and scaling is a common clinical feature. The consensus was to retain the disorder in the classification. Peeling skin disease (Fig 4, D) 124 has to be differentiated from NS. Unlike NS, peeling skin disease does not show hair anomalies, is not caused by SPINK5 mutations, 125 and has different immunochemical features, 126 but may also be accompanied by atopic diathesis.
3,124

Diseases related to inherited ichthyoses
A certain number of MEDOC forms can be regarded as phenotypically and/or etiologically related to ichthyosis, or have to be considered as differential diagnoses. Examples are the PPKs, which sometimes show nonacral involvement, eg, Vohwinkel keratoderma 127 caused by a particular dominant GJB2 mutation (connexin 26), 128 Mal de Meleda 129 caused by recessive SLURP1 mutations, 130 and Papillon-Lefèvre syndrome 131 caused by recessive CTSC mutations encoding cathepsin C. 132 Mutations in keratin 5 or 14 cause epidermolysis bullosa simplex, 133, 134 which can present with severe neonatal blistering clinically indistinguishable from EI. 62, 65, 135 Importantly, hypohidrosisea common symptom in ichthyoses, especially ARCI 136 erepresents one main criterion for the heterogeneous group of the ectodermal dysplasia. 137, 138 Generalized erythroderma with scaling, and even collodion membranes, have been described in single cases of hypohidrotic ectodermal dysplasia. 139, 140 One important differential diagnosis of HI (or severe collodion babies) is lethal restrictive dermopathy, [141] [142] [143] which is associated with intrauterine growth retardation, congenital contractures, tight skin, and ectropion, but does not develop hyperkeratosis and scaling. Another perinatal lethal syndrome, the Neu-Laxova syndrome, should be considered in neonates with ichthyosis and multiple anomalies, including tight translucent skin similar to that in restrictive dermopathy, abnormal facies with exophthalmos, marked intrauterine growth retardation, limb deformities, and central nervous system anomalies. 144 CHILD (congenital hemidysplasiaeichthyosiform nevuselimb defect) syndrome 145 is strictly limited to one half of the body and does not fulfill the ichthyosis criterion of a generalized cornification disorder; it is here considered ichthyosis related. Conradi-Hünermann-Happle (CDPX2) and CHILD syndrome are both caused by an enzyme defect within the distal cholesterol biosynthetic pathway as a result of X-linked dominant mutations in the EBP (CDPX2) and NSDHL (CHILD) genes, respectively. 84, 146 However, CDPX2 may present with severe CIE or collodion membrane and is therefore regarded as an ichthyosis (Fig 4,  F ) . 147 Darier disease 148, 149 and HaileyeHailey disease 150 are autosomal dominant genodermatoses 151, 152 The typical lesions of Darier diseaseeusually beginning in adolescenceeare tiny keratotic papules with a firmly adherent keratin cap, and are most often found on the seborrheic areas, scalp, and extremities; generalized involvement is very rare.
MODERN PATHOPHYSIOLOGIC VIEW Basic aspects for a functional understanding
Ichthyoses exhibit a generalized impaired desquamation as clinically evidenced by hyperkeratosis, scaling, or both. Desquamation is achieved by proteolytic degradation of the intercellular connectors, corneodesmosomes, aided by friction and corneocyte hydration. The process is based on normal epidermal differentiation and regulated by the balance of pH, protease inhibitors, and the generation of small hygroscopic molecules within the corneocyte. 8, 11 Through one defective pathway or another, all the ichthyoses result in varying degrees of abnormal epidermal differentiation and abnormal desquamation, eg, showing impaired corneocyte shedding (retention hyperkeratosis) or accelerated production (epidermal hyperplasia).
Concept of the impaired permeability barrier and homeostatic response
The SC provides a barrier, which abruptly impedes the outward movement of interstitial fluid at the SG/SC interface, [153] [154] [155] [156] and is formed by a series of highly hydrophobic lipid lamellae deposited through secretion of LB contents at the SG/SC interface between a mechanically resilient, yet pliable, scaffold of corneocytes. 157, 158 In recent years, it has become evident that this most critical SC functionethe permeability barriereis impaired in most ichthyosis forms. 11, 60, [159] [160] [161] [162] [163] [164] Several murine knockout models for ichthyosis [Spink5 (e/e), Tgm1 (e/e), Abca12 (e/e) mice, [165] [166] [167] Alox12b (e/e), 168 Cldn1(e/e) 169 ] have demonstrated neonatal lethality as a result of dehydration, underscoring the critical role of these genes in permeability barrier competence. Mutations that either alter the lipid composition of the SC membranesedisorders of lipid metabolismeor affect the function of the corneocyte structural proteinsedisorders of keratinocyte proteinseresult in increased water movement through the intercellular pathway. Therefore, the phenotypic expression Blood cell count (eosinophilia)
AD, Autosomal dominant; AR, autosomal recessive; CIE, congenital ichthyosiform erythroderma; CPK, creatine phosphokinase; EKV, erythrokeratodermia variabilis; IPS, ichthyosis prematurity syndrome; KG, keratohyaline granules; LB, lamellar body; PPK, palmoplantar keratoderma; SNHL, sensorineural hearing loss.
*May overlap with Clouston syndrome in rare cases.
y
To be differentiated from self-healing collodion baby (Table V) .
J AM ACAD DERMATOL VOLUME 63, NUMBER 4 CEDNIK, cerebral dysgenesiseneuropathyeichthyosisepalmoplantar keratoderma; CI, congential ichthyosis; CIE, congenital ichthyosiform erythroderma; EI, epidermolytic ichthyosis; EKV, erythrokeratodermia variabilis; ER, endoplasmatic reticulum; HI, harlequin ichthyosis; ICM, ichthyosis Curth-Macklin; IFAP, ichthyosis folliculariseatrichiaephotophobia; IHS, ichthyosis hypotrichosis syndrome; IHSC, ichthyosisehypotrichosisesclerosing cholangitis; IPS, ichthyosis prematurity syndrome; IV, ichthyosis vulgaris; KIF, keratin intermediate filament; LB, lamellar body; LI, lamellar ichthyosis; LK, loricrin keratoderma; MEDNIK, mental retardationeenteropathyedeafnesseneuropathyeichthyosisekeratodermia; NLPS, nonlamellar phase separations; NMF, natural moisturizing factor; NS, Netherton syndrome; RXLI, recessive X-linked ichthyosis; SC, stratum corneum; SEI, superficial epidermolytic ichthyosis; SHCB, self-healing collodion baby; SLS, Sjö gren-Larsson syndrome; TGase, transglutaminase; TFIIH, transcription factor II H; TTD, trichothiodystrophy.
of many ichthyoses should be analyzed within the context of stereotypical homeostatic response mechanisms that are activated by barrier abrogation in an attempt to restore the impaired barrier (and avoid lethal desiccation). For example, these mechanisms include delivery of preformed LB (within minutes), up-regulation of epidermal lipid synthesis (within hours), epidermal hyperproliferation (within days), and/or inflammation. 7, 8, 170 Healthy epidermis may need 3 to 7 days for complete barrier repair, 171 but in ichthyosis, where a genetic mutation produces an inherent epidermal barrier defect, repair efforts are continuously stimulated and do not terminate. 8 Differences in the pathogenetic mechanisms of these disorders have to be considered, but from a functional viewpoint, the ichthyosis skin phenotype may be regarded as a summation of the genetic epidermal barrier defect and the homeostatic response. 8, 172 This concept is illustrated by a recent mouse model, where Alox12b (e/e) skin was transplanted on nude mice. The neonatal Alox12b (e/e) mouse phenotype presented with thin, highly inflamed skin leading to dehydration and death within several hours (genetically impaired SC barrier), but the transplanted rescued adult phenotype of the lipoxygenase-deficient skin developed a mouse ichthyosis with severe hyperkeratosis (homeostatic response). 173 Such functional models correlate with the phenotypic shift in EI (or HI), where differences in barrier requirements between the wet intrauterine versus the dry postnatal environments produce strikingly different phenotypes at birth versus thereafter.
Toward a pathophysiologic classification
Unraveling the pathogenic sequence of each disorder from the responsible genetic cause to clinical disease expression is important for the development of new targeted therapies. A pathophysiologic/functional classification of all MEDOC is a long-term goal, which will require further studies before it can be fully realized. Currently, an initial pathophysiologic scheme for ichthyoses and related diseases is proposed recognizing the following main categories: disorders of keratinocyte proteins (''bricks''), eg, referring to cytoskeleton, cornified lipid/cell envelope, proteases/protease inhibitors, keratohyaline, and disorders of lipid metabolism, assembly, and/or transport (''mortar''), eg, referring to steroid sulfatase deficiency, the proposed hepoxilin pathway, 24 LB defects, and a variety of multisystem lipid metabolism defects such as lysosomal or neutral lipid storage disease. The inclusion of the connexin disorders, ie, EKV and KID, the ichthyosisehypotrichosisesclerosing cholangitis syndrome, and TTDs into the ichthyosis family indicates the additional categories of disorders of cell-cell junctions, and disorders of DNA transcription/repair, respectively. Table XII, open for inclusion of future new categories, summarizes the different groups and specifies the most important pathophysiologic aspects of each disorder as known to date.
DIAGNOSTIC ASPECTS Molecular genetics
The genetic causes, meaning the genes and pathogenic mutations, for most of the 36 forms of inherited ichthyoses (Tables I and II) have been successfully identified within the last two decades.* The molecular bases of only a few remain to be elucidated. The current classification was designed to reference each clinical diagnosis with the associated gene defect (Tables II and III) . Nevertheless, because of the genetic diversity and costs of testing, an initial carefully made clinical diagnosis, assisted by relevant laboratory and pathological evaluations, is essential to narrow the search for the affected gene (Fig 6) . Helpful contacts to initiate molecular diagnostic procedures are listed in Table XIV or can be provided by the authors (see http://www.netzwerk-ichthyose.de/ index.php?id=27&L=1). In consanguineous populations, homozygosity mapping may be a screening test to identify the causative gene, while saving time and reducing diagnostic costs. 187, 188 It is of note that in some patients with an ichthyosis with a welldefined genetic basis, even extensive gene sequencing does not identify the pathogenic mutation or mutations, eg, in KPI. 189 In summary, molecular diagnosis is a crucial diagnostic tool and has become in some countries the gold standard for the diagnosis of the ichthyoses and MEDOC in general. It provides a firm basis for genetic counseling of affected individuals and families and permits DNA-based prenatal diagnosis for families at risk, as has been demonstrated in NS, [190] [191] [192] KPI, [193] [194] [195] Sjögren-Larsson syndrome, 196 HI, 197, 198 and others.
Use of ultrastructural analyses
In disorders of cornification, subcellular changes that occur in the keratinocyte organelles and structural proteins are even more heterogeneous than expected from the clinical and light microscopic view alone. Transmission electron microscopy (EM) is therefore a valuable tool and may provide important clues to the clinical diagnosis of the ichthyoses by identification of consistent and sometimes highly specific ultrastructural markers. 54, 164, 199, 200 Given appropriate expertise, about 30% to 40% of patients with a suspected form of ichthyosis can be classified based on conventional ultrastructural criteria, ie, certain types of ichthyosis may be excluded, or the list of differential diagnoses may be narrowed. For example, in IV a pronounced rarefaction of keratohyaline granules can be visualized, 201 and the extent of this ultrastructural abnormality correlates with the presence of one or two loss-of-function mutations in the FLG gene, encoding filaggrin. 202 RXLI typically shows retained corneodesmosomes within the SC and nonlamellar phase separation in the SC interstices, provided that a ruthenium tetroxide fixation (see below) has been performed. 7, 8 HI exhibits abnormal LB, 203 with a marked deficiency of intercellular lamellae in the SC. 16, 204 Disruption of the keratin cytoskeleton, with detachment from the desmosomal plaques and often perinuclear shell formation is observed in the KPI. 50, 51, 53, 54, 62, 65, 176 Abnormal intranuclear granules seen in the SG and SC are observed in loricrin keratoderma, which is ultrastructurally further characterized by a reduced thickness of the cornified cell envelope. 96, 205 A markedly thinned cornified cell envelope throughout the SC is typical for TGase-1 deficiency. 160 The ultrastructural features of the so-called EM classification described by the Heidelberg group are based on a glutaraldehyde fixation of the skin biopsy specimen. [206] [207] [208] [209] [210] With this technique polygonal clefts in the SC can be observed as an ultrastructural key feature of TGase-1 deficiency, 211 aberrant vesicular structures may indicate NIPAL4 (;ICHTHYIN ) mutations in ARCI, 33 and trilamellar membrane aggregations in the SC and SG (EM type IV) are pathognomonic for ichthyosis prematurity syndrome. 89 Detachment of the SC from the SG with asymmetric cleavage of corneodesmosomes is a specific feature of NS. 165, 212 The image of the SC as viewed by conventional EM is still artifactual. In frozen sections, where lipid extraction is avoided, eg, by hydrophilic staining procedures, the compact structure of the SC can be appreciated. Similarly, the recent development of both osmium tetroxide and ruthenium tetroxide postfixation enables improved visualization of extracellular lipids, postsecretory changes in LB contents, and alterations of the lamellar bilayers in the SC, eg, lamellar/nonlamellar phase separation. 7 The combination of all alterations observed with this technique may be diagnostic for many forms of ichthyosis. 8 Most importantly, the ultrastructural demonstration of disturbances of lipid metabolism gives valuable insights into the pathophysiologic basis of many ichthyoses 11, 60, [159] [160] [161] [162] [163] [164] and enables a function-driven approach. 7, 8, 11 Histopathology, immunochemistry, and other nongenetic analyses Routine histopathological findings in most ichthyoses are nondiagnostic, often demonstrating only epidermal hyperplasia and varying degrees of orthohyperkeratosis. In combination with characteristic features, routine histology can give an important clue for IV 213, 214 or EI. 52, 61, 62, 215, 216 However, one should consider that a reduced or absent SG suggestive for IV can also be seen in acquired ichthyosis, NS, Refsum syndrome, TTDs, or Conradi-Hünermann-Happle syndrome. Hair mounts can demonstrate bamboo hairs (trichorrhexis invaginata) in NS 123 ; although not invariably present, bamboo hairs are pathognomonic of this disorder. Parakeratosis and hypergranulosis is regarded a histopathological clue to loricrin keratoderma. 96, 205 Polarization microscopy can demonstrate the tiger-tail pattern of TTD, 217 ,218 which corresponds to the diagnostic low-sulfur protein content of the hair. 219, 220 Special immunohistochemical procedures can be combined, eg, to confirm filaggrin deficiency in IV, 202, 221 or demonstrate absent or reduced expression of LEKTI that supports the diagnosis of NS. [222] [223] [224] To screen for TGase-1 deficiency in ARCI unfixed cryostat sections are used for the enzyme activity assay. 225, 226 Alternatively, superficial SC material can be subjected to a SDS heating test that visualizes absent cross-linked envelopes in TGase-1 deficiency. 227 There are special useful analyses given in Tables IV to XII. For instance, steroid sulfatase deficiency underlying RXLI can be demonstrated by reduced arylsulfatase-C activity of leukocytes, or can readily be diagnosed by the widely available fluorescent in situ hybridization test for the STS gene region, because more than 90% of the cases are caused by a gene deletion. Gas chromatography-mass spectrometry reveals elevated serum levels of 8-dehydrocholesterol and cholesterol in Conradi-Hünermann-Happle syndrome and can identify a somatic EBP gene mosaicism in unaffected individuals. 228 
RESOURCES FOR CLINICIANS AND PATIENTS
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